Search
This search looks for keywords in all of the website’s content. You can also download all of our medicine data. More help: search tips
Filter by
- Agenda(0)
- Annex to CHMP highlights(0)
- Annual Report(0)
- Application withdrawal assessment report(0)
- Committee meeting report(0)
- COVID-19 vaccine safety update(0)
- Direct healthcare professional communication(0)
- EPAR - All authorised presentations(0)
- EPAR - Amended Product Information(0)
- EPAR - Assessment report - Variation(0)
- EPAR - Assessment report on maintenance of orphan designation - Initial authorisation(0)
- EPAR - Assessment report on maintenance of orphan designation - Post-authorisation(0)
- EPAR - Conditions imposed on member states for safe and effective use(0)
- EPAR - Overview(0)
- EPAR - Paediatric investigation plan compliance statement(0)
- EPAR - Procedural steps taken and scientific information after authorisation(0)
- EPAR - Procedural steps taken before authorisation(0)
- EPAR - Product Information(0)
- EPAR - Product Information tracked changes(0)
- EPAR - Public assessment report(0)
- EPAR - Risk-management-plan summary(0)
- EPAR - Risk management plan(0)
- EPAR - Scientific conclusion(0)
- EPAR - Scientific Discussion(0)
- EPAR - Scientific Discussion - Variation(0)
- EPAR - Steps taken after authorisation when a cutoff date has been used(0)
- Herbal - Call for data(0)
- Herbal - Herbal monograph(0)
- Herbal - HMPC assessment report(0)
- Herbal - HMPC opinion on a European Union herbal monograph(0)
- Herbal - List of references supporting the assessment report(0)
- Herbal - Overview of comments received during consultation(0)
- Herbal - Summary of assessment report for the public(0)
- Herbal – European Union herbal monograph(0)
- Herbal – European Union list entry(0)
- Leaflet(0)
- Maximum Residue Limits - Divergent opinion(0)
- Maximum Residue Limits - Opinion(0)
- Maximum Residue Limits - Report(0)
- Maximum Residue Limits - Summary of opinion(0)
- Medicine QA(0)
- Medicines under additional monitoring(0)
- Minutes(0)
- Newsletter(0)
- Opinion on any scientific matter(0)
- Opinion outside EU - All presentations(0)
- Opinion outside EU - Assessment report - Variation(0)
- Opinion outside EU - Medicine questions and answers(0)
- Opinion outside EU - Procedural steps taken and scientific information after opinion(0)
- Opinion outside EU - Procedural steps taken before opinion(0)
- Opinion outside EU - Product information(0)
- Opinion outside EU - Public assessment report(0)
- Opinion outside EU - Risk-management-plan summary(0)
- Opinion outside EU - Scientific discussion(0)
- Opinion outside EU - Summary for the public(0)
- Opinion outside EU - Summary of opinion(0)
- Opinion outside EU - Summary of opinion - Initial authorisation(0)
- Opinion outside EU - Withdrawal assessment report(0)
- Orphan designation(0)
- Orphan review(0)
- Other(0)
- Overview of comments(0)
- Periodic safety update single assessment(0)
- PIP - Notification of discontinuation of a paediatric development which is covered by an agreed PIP decision(0)
- PIP - Paediatric-investigation-plan summary(0)
- PIP decision(0)
- Position statement(0)
- PRAC recommendation on signal(0)
- Presentation(0)
- Press Release(0)
- Procurement(0)
- Public Statement(0)
- Recommendation on medication errors(0)
- Recruitment(0)
- Referrals document(0)
- Regulatory and procedural guideline(0)
- Report(0)
- Scientific guideline(0)
- Standard Operating Procedure - SOP(0)
- Summary of opinion(0)
- Summary of opinion - Initial authorisation(0)
- Template or form(0)
- Withdrawal letter(0)
- Work Instruction - WIN(0)
- Work programme(0)
- Advanced therapies(0)
- Antimicrobial resistance(0)
- Biologicals(0)
- Biosimilars(0)
- Brexit(0)
- Careers(0)
- Clinical trials(0)
- Compassionate use(0)
- Compliance and inspections(0)
- Corporate(0)
- COVID-19(0)
- Data on medicines(0)
- Early access(0)
- Fees(0)
- Generic and hybrid medicines(1)
- Governance(0)
- Innovation(0)
- Maximum residue limit(0)
- Medical devices(0)
- Medication error(0)
- Medicines(5)
- Medicines for use outside the EU(0)
- Medicine shortages(0)
- Mpox(0)
- Paediatrics(4)
- Parallel distribution(0)
- Pharmacovigilance(2)
- Procurement(0)
- Product information(0)
- Quality of medicines(0)
- Rare diseases(1)
- Referrals(0)
- Regulatory and procedural guidance(0)
- Research and development(0)
- Scientific advice(0)
- Scientific guidelines(0)
- SME(0)
- Vaccines(0)
- Veterinary limited markets(0)
Search results (9)
cyanocobalamin, folic acid, pyridoxine
Procedure number:
PSUSA/00000893/202411
Regulatory outcome:
Maintenance
Last updated:
10 July 2025
PSUSAHuman
betaine anhydrous
Homocystinuria
Date of authorisation:
Revision:
15
Last updated:
12 December 2024
MedicineHumanAuthorised
cyanocobalamin, diclofenac, pyridoxine, thiamine
Procedure number:
PSUSA/00001041/202001
Regulatory outcome:
Maintenance
Last updated:
5 December 2023
PSUSAHuman
Decision type:
W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area:
Pain
PIP number:
P/0035/2023
Route(s) of administration:
Intramuscular use
Pharmaceutical form(s):
Treatment of familial Mediterranean fever
Decision date:
31 January 2023
Last updated:
9 November 2023
Compliance check:
✖
PIPHuman
Decision type:
W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area:
Immunology-Rheumatology-TransplantationPain
PIP number:
P/0499/2022
Route(s) of administration:
Oral use
Pharmaceutical form(s):
Film-coated tablet
Decision date:
2 December 2022
Last updated:
24 October 2023
Compliance check:
✖
PIPHuman
betaine anhydrous
Homocystinuria
Date of authorisation:
Last updated:
8 June 2023
MedicineHumanAuthorised
Decision type:
W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area:
Endocrinology-Gynaecology-Fertility-Metabolism
PIP number:
P/0410/2021
Route(s) of administration:
Oral use
Pharmaceutical form(s):
Prolonged-release tablet
Decision date:
29 October 2021
Last updated:
13 February 2023
Compliance check:
✖
PIPHuman
Date of designation:
27 June 2016
Positive
Last updated:
26 July 2016
OrphanHuman
Decision type:
W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area:
Endocrinology-Gynaecology-Fertility-Metabolism
PIP number:
P/0140/2014
Route(s) of administration:
Oral use
Pharmaceutical form(s):
Gastro-resistant tablet
Decision date:
11 June 2014
Last updated:
22 July 2014
Compliance check:
✖
PIPHuman